The following trials provide information to treat various types of cardiovascular diseases, both for ongoing and completed clinical trials. For more information on this therapy area please click here.
- collapse Non-interventional study to assess reaching of cholesterol target values in patients treated with HMG-CoA reductase inhibitors in Bosnia and Herzegovina
- collapse Centralised Pan-Algerian Survey on the undertreatment of hypercholesterolemia
- collapse An observational study of statin treatment induced HDL changes - effect on cardiovascular disease
- collapse Observational study to understand patients’ and physicians’ attitudes to Statins in Turkey
- collapse A Double Masked, Placebo Controlled, Randomised, Parallel Group Phase IIa Study to assess the Tolerability, Safety, and Efficacy of AZD4017 for Raised Intra-Ocular Pressure
- collapse Effectiveness of risk minimisation interventions for ticagrelor in Canada
- collapse A 24-week, Multicentre, Randomised, Double-Blind, Placebo-Controlled, International Phase III Study With a 28-week Extension Period to Evaluate the Safety and Efficacy of Dapagliflozin 10mg Once Daily in Patients With Type 2 Diabetes Who Have Inadequate Glycaemic Control on a Background Combination of Metformin and Sulfonylurea
- collapse A 24-week National Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase III Trial in India to Evaluate the Efficacy and Safety of Dapagliflozin as Monotherapy in Subjects with Type 2 Diabetes Who have Inadequate Glycaemic Control with Diet and Exercise alone.
- collapse Health DB Sicilia (HEALTH-DB ACS)
- collapse A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Relieving Opioid-Induced Constipation (OIC) in Patients With Cancer-Related Pain
